Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 05 Jun 2020

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China

in Thoracic Oncology

Muhammad Abbas
Said Abasse Kassim
Murad Habib
Xiaoyou Li
Meiqi Shi
Zhong-Chang Wang
Yiqiao Hu
Hai-Liang Zhu

Frontiers in Oncology

doi 10.3389/fonc.2020.00800

10,466 views
23 citations

Mini Review

Published on 03 Jun 2020

Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma

in Thoracic Oncology

Robert A. Belderbos
Heleen Vroman
Joachim G. J. V. Aerts

Frontiers in Oncology

doi 10.3389/fonc.2020.00777

5,100 views
10 citations

Original Research

Published on 27 May 2020

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies

in Thoracic Oncology

Liang Xue
Guoshu Bi
Cheng Zhan
Yi Zhang
Yunfeng Yuan
Hong Fan

Frontiers in Oncology

doi 10.3389/fonc.2020.00835

6,188 views
18 citations

Mini Review

Published on 20 May 2020

Targeted Therapies and Biomarkers in Small Cell Lung Cancer

in Thoracic Oncology

Hirokazu Taniguchi
Triparna Sen
Charles M. Rudin

Frontiers in Oncology

doi 10.3389/fonc.2020.00741

35,559 views
92 citations

Original Research

Published on 19 May 2020

Patterns of Extrathoracic Metastases in Different Histological Types of Lung Cancer

in Thoracic Oncology

Xuan Wang
Zheng Wang
Junjie Pan
Zhou-Yi Lu
Dong Xu
Hui-Jun Zhang
Shao-Hua Wang
Da-Yu Huang
Xiao-Feng Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.00715

14,903 views
50 citations

Original Research

Published on 15 May 2020

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer

in Thoracic Oncology

Bo Hao
Lin Zhang
Tao Fan
Bohao Liu
Wenyang Jiang
Hao Hu
Qing Geng

Frontiers in Oncology

doi 10.3389/fonc.2020.00661

5,586 views
3 citations

Case Report

Published on 15 May 2020

Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung

in Thoracic Oncology

Valentina Masciale
Giulia Grisendi
Federico Banchelli
Roberto D'Amico
Antonino Maiorana
Pamela Sighinolfi
Lucio Brugioni
Alessandro Stefani
Uliano Morandi
Massimo Dominici

Frontiers in Oncology

doi 10.3389/fonc.2020.00673

17,072 views
7 citations

Original Research

Published on 13 May 2020

Preoperative Prediction of Lymph Node Metastasis in Patients With Early-T-Stage Non-small Cell Lung Cancer by Machine Learning Algorithms

in Thoracic Oncology

Yijun Wu
Jianghao Liu
Chang Han
Xinyu Liu
Yuming Chong
Zhile Wang
Liang Gong
Jiaqi Zhang
Xuehan Gao
Chao Guo

Frontiers in Oncology

doi 10.3389/fonc.2020.00743

6,664 views
34 citations

Perspective

Published on 12 May 2020

Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic

in Thoracic Oncology

Alex Friedlaender
Chul Kim
Alfredo Addeo

Frontiers in Oncology

doi 10.3389/fonc.2020.00862

11,280 views
36 citations

Original Research

Published on 08 May 2020

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients

in Thoracic Oncology

Zihuan Zhao
Dan Zhao
Ji Xia
Yi Wang
Buhai Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.00691

8,747 views
22 citations

Original Research

Published on 29 Apr 2020

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non–Small Cell Lung Cancer

in Thoracic Oncology

Chen Lin
Xun Shi
Jun Zhao
Qiong He
Yun Fan
Weizhen Xu
Yang Shao
Xinmin Yu
Ying Jin

Frontiers in Oncology

doi 10.3389/fonc.2020.00480

8,590 views
34 citations

Review

Published on 28 Apr 2020

Oral Chemotherapy for Treatment of Lung Cancer

in Thoracic Oncology

Sushma Jonna
Joshua E. Reuss
Chul Kim
Stephen V. Liu

Frontiers in Oncology

doi 10.3389/fonc.2020.00793

33,123 views
13 citations

Original Research

Published on 28 Apr 2020

Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer

in Thoracic Oncology

Yuxin Mu
Ke Yang
Xuezhi Hao
Yan Wang
Lin Wang
Yutao Liu
Lin Lin
Junling Li
Puyuan Xing

Frontiers in Oncology

doi 10.3389/fonc.2020.00603

12,673 views
32 citations

Case Report

Published on 28 Apr 2020

Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature

in Thoracic Oncology

Yu Chen
Zhaoqin Huang
Ligang Xing
Xiangjiao Meng
Jinming Yu

Frontiers in Oncology

doi 10.3389/fonc.2020.00561

6,893 views
30 citations

Original Research

Published on 24 Apr 2020

Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database

in Thoracic Oncology

Yuyan Wang
Qiwen Zheng
Bo Jia
Tongtong An
Jun Zhao
Meina Wu
Minglei Zhuo
Jianjie Li
Jia Zhong
Hanxiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.00626

6,248 views
25 citations

Systematic Review

Published on 23 Apr 2020

A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs

in Thoracic Oncology

Elizabeth Pan
David Bogumil
Victoria Cortessis
Sherrie Yu
Jorge Nieva

Frontiers in Oncology

doi 10.3389/fonc.2020.00591

16,345 views
35 citations

Original Research

Published on 22 Apr 2020

Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model

in Thoracic Oncology

Filippo de Marinis
Ilaria Attili
Stefania Morganti
Valeria Stati
Gianluca Spitaleri
Letizia Gianoncelli
Ester Del Signore
Chiara Catania
Cristiano Rampinelli
Emanuela Omodeo Salè

Frontiers in Oncology

doi 10.3389/fonc.2020.00665

9,563 views
22 citations

Original Research

Published on 21 Apr 2020

Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual

in Thoracic Oncology

Lei-Lei Wu
Xuan Liu
Wen-Mei Jiang
Wei Huang
Peng Lin
Hao Long
Lan-Jun Zhang
Guo-Wei Ma

Frontiers in Oncology

doi 10.3389/fonc.2020.00571

7,900 views
33 citations

Original Research

Published on 15 Apr 2020

BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining

in Thoracic Oncology

Ke-Wei Bi
Xu-Ge Wei
Xiao-Xue Qin
Bo Li

Frontiers in Oncology

doi 10.3389/fonc.2020.00424

41,022 views
116 citations

Case Report

Published on 15 Apr 2020

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer

in Thoracic Oncology

Tejas Patil
Jose M. Pacheco
Anastasios Dimou
William T. Purcell
Candice Rossi
Paul A. Bunn
Robert C. Doebele
D. Ross Camidge
Lisa Ferrigno

Frontiers in Oncology

doi 10.3389/fonc.2020.00510

5,117 views
3 citations

Review

Published on 03 Apr 2020

Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation

in Thoracic Oncology

Luca Ferrari
Michele Carugno
Carolina Mensi
Angela Cecilia Pesatori

Frontiers in Oncology

doi 10.3389/fonc.2020.00445

6,380 views
23 citations

Review

Published on 25 Mar 2020

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models

in Thoracic Oncology

Christophe Blanquart
Marie-Claude Jaurand
Didier Jean

Frontiers in Oncology

doi 10.3389/fonc.2020.00388

12,164 views
34 citations

Original Research

Published on 20 Mar 2020

Development of a Survival Prognostic Model for Non-small Cell Lung Cancer

in Thoracic Oncology

Yue-Hua Zhang
Yuquan Lu
Hong Lu
Yue-Min Zhou

Frontiers in Oncology

doi 10.3389/fonc.2020.00362

6,363 views
22 citations

Review

Published on 12 Mar 2020

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?

in Thoracic Oncology

Luca Cantini
Raffit Hassan
Daniel H. Sterman
Joachim G. J. V. Aerts

Frontiers in Oncology

doi 10.3389/fonc.2020.00343

17,183 views
59 citations

1,971 articles

articles

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China

Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies

Targeted Therapies and Biomarkers in Small Cell Lung Cancer

Patterns of Extrathoracic Metastases in Different Histological Types of Lung Cancer

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer

Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung

Preoperative Prediction of Lymph Node Metastasis in Patients With Early-T-Stage Non-small Cell Lung Cancer by Machine Learning Algorithms

Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non–Small Cell Lung Cancer

Oral Chemotherapy for Treatment of Lung Cancer

Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer

Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature

Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database

A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs

Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model

Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual

BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer

Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models

Development of a Survival Prognostic Model for Non-small Cell Lung Cancer

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?